FDA Inspection 1319110 — SGS Lab Simon
The FDA completed an inspection of SGS Lab Simon on Feb 16, 2026 in Wavre. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 16, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Wavre (Belgium)